Literature DB >> 23628768

Osteoarthritis: chondroprotection by histone deacetylase inhibition.

Emma Leah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23628768     DOI： 10.1038/nrrheum.2013.63

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation.

Authors:  Kirsty L Culley; Wang Hui; Matt J Barter; Rose K Davidson; Tracey E Swingler; Auriane P M Destrument; Jenny L Scott; Simon T Donell; Steve Fenwick; Andrew D Rowan; David A Young; Ian M Clark
Journal:  Arthritis Rheum       Date:  2013-07
  1 in total
  2 in total

1.  Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.

Authors:  Lomeli R Carpio; Elizabeth W Bradley; Meghan E McGee-Lawrence; Megan M Weivoda; Daniel D Poston; Amel Dudakovic; Ming Xu; Tamar Tchkonia; James L Kirkland; Andre J van Wijnen; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Sci Signal       Date:  2016-08-09       Impact factor: 8.192

2.  Upregulation of Bone Morphogenetic Protein-2 Synthesis and Consequent Collagen II Expression in Leptin-stimulated Human Chondrocytes.

Authors:  Shun-Fu Chang; Rong-Ze Hsieh; Kuo-Chin Huang; Cheng Allen Chang; Fang-Yao Chiu; Hsing-Chun Kuo; Cheng-Nan Chen; Yu-Ping Su
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.